Page last updated: 2024-08-23

diltiazem and Cancer of Prostate

diltiazem has been researched along with Cancer of Prostate in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biswas, G; Jindal, T; Karmakar, D; Mandal, SN1
King, Q; Marshall, D; Siva, G; Zargar, H1
Al-Husein, B; Al-Shabrawey, M; Bollag, WB; Choudhary, V; Davis, M; Dong, Z; El Gaish, M; Kaddour-Djebbar, I; Kumar, MV; Lakshmikanthan, V; Shirley, R; Zhong, R1
Chao, YY; Jan, CR1

Trials

2 trial(s) available for diltiazem and Cancer of Prostate

ArticleYear
Evaluation of the efficacy of a combination of diltiazem and periprostatic nerve block in pain control during transrectal ultrasonography-guided biopsy of the prostate.
    Annals of the Royal College of Surgeons of England, 2013, Volume: 95, Issue:5

    Topics: Administration, Topical; Aged; Aged, 80 and over; Anesthetics, Local; Biopsy; Calcium Channel Blockers; Combined Modality Therapy; Diltiazem; Gels; Humans; Lidocaine; Male; Middle Aged; Nerve Block; Pain; Pain Management; Prostate; Prostatic Neoplasms; Ultrasonography, Interventional

2013
Topical diltiazem before transrectal ultrasonography-guided biopsy of the prostate: a randomized controlled trial.
    ANZ journal of surgery, 2015, Volume: 85, Issue:6

    Topics: Administration, Topical; Adult; Aged; Anesthetics, Local; Biopsy; Combined Modality Therapy; Diltiazem; Double-Blind Method; Humans; Male; Middle Aged; Nerve Block; Pain Measurement; Prostate; Prostatic Neoplasms; Treatment Outcome; Ultrasonography, Interventional

2015

Other Studies

2 other study(ies) available for diltiazem and Cancer of Prostate

ArticleYear
Diltiazem enhances the apoptotic effects of proteasome inhibitors to induce prostate cancer cell death.
    The Journal of pharmacology and experimental therapeutics, 2012, Volume: 341, Issue:3

    Topics: Acetylcysteine; Apoptosis; Blotting, Western; Boronic Acids; Bortezomib; Calcium; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Humans; Male; Prostatic Neoplasms; Protease Inhibitors; Pyrazines; Transfection; Tumor Cells, Cultured

2012
Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells.
    Cellular signalling, 2004, Volume: 16, Issue:8

    Topics: Adenosine Triphosphate; Azepines; Calcium; Calcium Signaling; Cell Proliferation; Dihydropyridines; Diltiazem; Enzyme Inhibitors; Fura-2; Humans; Male; Phorbol Esters; Platelet Membrane Glycoproteins; Prostatic Neoplasms; Protein Kinase C; Receptors, G-Protein-Coupled; Signal Transduction; Thapsigargin; Triazoles; Tumor Cells, Cultured; Verapamil

2004